The ventilators market is growing exponentially during the pandemic, due to its application to treat patients with severe Covid-19. According to GlobalData analysis, prior to the Covid-19 pandemic, the global ventilators market was valued at $1.1B in 2019, growing at an annual rate of 3.5%. GlobalData expects the market to reach $5.2B in 2020, with a gradual decrease in growth of sales in coming years due to its load purchasing in 2020.

Covid-19 has led to a surge in demand for ventilators that ventilator manufacturers cannot meet from existing inventory and that outstrips normal production rates. All ventilator manufacturers have full order books and hold little in stock, receiving orders not only from regular customers like hospitals, but also directly from governments. The companies aim to at least double their capacity in 2020.

To meet the demand, the manufacture of ventilators during Covid-19 relies on partnerships between medical manufacturers and companies that can provide additional production capacity. To date, the most successful partnerships are between existing ventilator manufacturers and large engineering companies, through expansion of manufacturing scale for existing or lightly modified versions of existing approved ventilators.

Many regulatory authorities accelerated the approval process for emergency ventilators. The FDA has waived the submission of premarket notification of modified ventilators in the US where the modification will not give rise to an undue concern, and allows alternative devices capable of delivering breath or pressure support during the Covid-19 pandemic.

The majority of the prototypes built for the pandemic are portable transport ventilators. Most devices had received regulatory approval prior to the outbreak. They offer critical care patient support for all age groups. Some are pneumatically powered and have no need for batteries or electrical power, making them suitable for transport or makeshift spaces. Some emergency ventilators tailored for Covid-19 patients only meet the minimally clinically acceptable standards, and they are only intended to last three to four months.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.